CSNK2B
MOLECULAR TARGETcasein kinase 2 beta
CSNK2B (casein kinase 2 beta) is targeted by 10 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting CSNK2B
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | Emodin Purgative anthraquinone found in several plants, especially RHAMNUS PURSHIANA. It was formerly used as | 2.30 | 9 |
| 2 | Quercetin | 2.08 | 7 |
| 3 | Apigenin 5,7,4'-trihydroxy-flavone, | 1.95 | 6 |
| 4 | fisetin | 1.79 | 5 |
| 5 | Luteolin 5,7,3',4'-tetrahydroxy-flavone, | 1.79 | 5 |
| 6 | Kaempferols | 1.61 | 4 |
| 7 | myricetin-3-O-galactopyranoside [Supplementary Concept] | 1.61 | 4 |
| 8 | chrysin | 1.10 | 2 |
| 9 | Vanillic Acid | 1.10 | 2 |
| 10 | ly294002 | 1.10 | 2 |
About CSNK2B as a Drug Target
CSNK2B (casein kinase 2 beta) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 10 compounds with documented CSNK2B interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
CSNK2B inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.